Latest revenue
$139.5K
as of 2026-01-31
Latest net income
$-126.6K
as of 2026-01-31
Net margin
-90.8%
as of 2026-01-31
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $80.7M
- Enterprise value
- $80.7M
- P/E (trailing)
- —
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- 52-wk high
- $10.30
- 52-wk low
- $0.05
- Beta
- —
- Shares out
- 79.9M
5-year trend
What this company does
General Overview We were incorporated under the laws of the State of Nevada on May 20, 2014. We intend to offer management and consulting services to healthcare organizations. We intend to focus on ambulatory surgical centers (ASCs) that currently have an incentive to be acquired by hospitals in order to increase compensation levels. We believe the short term strategy of converting to hospital based compensation is not sustainable because fundamental changes in the way healthcare is being provided are being undertaken by both government and private insurance carriers. The demographics of an aging population also mandate such changes to avoid economic disruption, healthcare rationing or…
AI summary unavailable — showing raw filing excerpt
Generated from PHCI's filing dated 2019-10-29
Key risks
As a “smaller reporting company”, we are not required to provide the information required by this Item.
AI summary unavailable — showing raw filing excerpt
Generated from PHCI's filing dated 2019-10-29
Profitability
Gross margin
25.5%
38.2%Operating margin
-226.0%
99.7%Net margin
-222.2%
99.7%Return on equity
-85.9%
99.7%Return on assets
-66.8%
99.5%Leverage
Debt / equity
0.29×
74.7%Debt / assets
22.3%
58.0%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-01-31 | $139.5K | — | $-126.6K | -26.6% | -90.8% |
Q4 2025 2025-10-31 | $0 | -100.0% | $-153.7M | -211651.2% | — |
Q3 2025 2025-07-31 | $164.2K | +735.8% | $-248.0K | +96.7% | -151.1% |
Q2 2025 2025-04-30 | $69.3K | — | $-115.8K | +98.5% | -167.0% |
Q1 2025 2025-01-31 | $0 | — | $-100.0K | -140.1% | — |
Q4 2024 2024-10-31 | $7.9K | — | $-72.6K | -15.2% | -918.0% |
Q3 2024 2024-07-31 | $19.6K | — | $-7.6M | — | -38849.8% |
Q2 2024 2024-04-30 | $0 | — | $-7.5M | — | — |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Services-Management Consulting Services · SIC 8742
Your notes
Keep private notes on PHCI — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$0
Insider selling
$0
Net activity
+$0
Distinct insiders
0
Open-market trades over the last 365 days.
Recent transactions
| Date | Insider | Type | Shares | Price | Value |
|---|
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns PHCI
No institutional holdings on file for PHCI yet.
Source: SEC Form 13F-HR. Updated quarterly (45-day filing lag).
Top questions investors are asking
Coming once PHCI's latest filing finishes processing.